C.M. Bidwell & Associates’s Accendra Health ACH Stock Holding History

C.M. Bidwell & Associates’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,830	Closed	-$331K	–	598
2021 Q2	$331K	Buy	7,830 +7,265	+1,286%	+$283K	0.22%	76
2021 Q1	$21K	Hold	565	–	–	0.02%	346
2020 Q4	$15K	Sell	565 -395	-41%	-$10.2K	0.01%	350
2020 Q3	$24K	Buy	+960	New	+$14K	0.02%	299
2016 Q2	–	Sell	-10,625	Closed	-$429K	–	299
2016 Q1	$429K	Buy	+10,625	New	+$396K	0.11%	108
2014 Q2	–	Sell	-4,970	Closed	-$174K	–	278
2014 Q1	$174K	Buy	+4,970	New	+$175K	0.04%	164

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

C.M. Bidwell & Associates's ACH Position: Q3 2021 in Review

C.M. Bidwell & Associates sold out of Accendra Health (ACH) in Q3 2021, closing a stake of 7,830 shares — an estimated $331K sold.

C.M. Bidwell & Associates first reported a position in ACH in Q1 2014 and held it in 6 quarters. The position peaked at $429K in Q1 2016. 247 funds tracked by Wall St. Rank hold ACH as of Q3 2021.

C.M. Bidwell & Associates reported no remaining Accendra Health position as of Q3 2021 after selling out during the quarter.
C.M. Bidwell & Associates sold 7,830 Accendra Health shares in Q3 2021, an estimated $331K.
C.M. Bidwell & Associates first reported a position in Accendra Health in Q1 2014 and held it in 6 quarters.
C.M. Bidwell & Associates's Accendra Health position peaked at $429K in Q1 2016.
247 funds tracked by Wall St. Rank held Accendra Health as of Q3 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2021, filed 12 Nov 2021.